Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps, Gut Microbes, vol.3, issue.3, pp.203-223, 2012. ,
Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders, Obes Silver Spring Md, vol.26, issue.5, pp.792-800, 2018. ,
Gut metagenome in European women with normal, impaired and diabetic glucose control, Nature, vol.498, issue.7452, pp.99-103, 2013. ,
Human gut microbes impact host serum metabolome and insulin sensitivity, Nature, vol.535, issue.7612, pp.376-81, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01594855
Richness of human gut microbiome correlates with metabolic markers, Nature, vol.500, issue.7464, pp.541-547, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01190602
Dietary intervention impact on gut microbial gene richness, Nature, vol.500, issue.7464, pp.585-593, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01001543
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome, Cell Host Microbe, vol.17, issue.4, pp.213-236, 2008. ,
Human gut microbiome viewed across age and geography, Nature, vol.486, issue.7402, pp.222-229, 2012. ,
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery, Gut, 2018. ,
This study demonstrate that severe obesity is associated with a dramatic increased prevalence of low MGR. Bariatric surgery is able to partially restore gut microbiota dysbiosis ,
A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, vol.490, issue.7418, pp.55-60, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01204262
Aberrant intestinal microbiota in individuals with prediabetes, Diabetologia, vol.61, issue.4, pp.810-830, 2018. ,
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes, Curr Diab Rep, vol.18, issue.8, p.55, 2018. ,
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome? Semin Immunopathol, 2019. ,
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, Gut, vol.58, issue.8, pp.1091-103, 2009. ,
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women, Gut, vol.62, issue.8, pp.1112-1133, 2013. ,
Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, Obese Prediabetic Individuals, vol.153, pp.87-97, 2017. ,
Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials, BMJ Open, vol.9, issue.3, p.17995, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02165922
Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity, Sci Transl Med, vol.5, issue.178, pp.178-219, 2013. ,
Rouxen-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation, Cell Metab, vol.22, issue.2, pp.228-266, 2015. ,
Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection, Am J Gastroenterol, vol.107, issue.7, pp.1079-87, 2012. ,
Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection, Am J Gastroenterol, vol.107, issue.5, pp.761-768, 2012. ,
Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results, J Clin Gastroenterol, vol.46, issue.2, pp.145-154, 2012. ,
Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection, Gastroenterology, vol.142, issue.3, pp.490-496, 2012. ,
Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.53, issue.10, pp.994-1002, 2011. ,
Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results, J Gastroenterol Hepatol, vol.30, issue.1, pp.51-59, 2015. ,
Duodenal infusion of donor feces for recurrent Clostridium difficile, N Engl J Med, vol.368, issue.5, pp.407-422, 2013. ,
, This RCT is the first to demonstrate the efficacy of FMT to cure clostridium difficile infection
Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.58, issue.11, pp.1515-1537, 2014. ,
, This study demonstrate for the first time the efficacy of capsulized oral fecal microbiota transfer
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, Aliment Pharmacol Ther, vol.41, issue.9, pp.835-878, 2015. ,
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial, JAMA, vol.315, issue.2, pp.142-151, 2016. ,
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection, Aliment Pharmacol Ther, vol.46, issue.5, pp.479-93, 2017. ,
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections, Am J Gastroenterol, vol.108, issue.4, pp.478-98, 2013. ,
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, issue.2, pp.1-26, 1920. ,
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA), Clin Infect Dis Off Publ Infect Dis Soc Am, vol.66, issue.7, pp.987-94, 2018. ,
Consensus report: faecal microbiota transfer -clinical applications and procedures, Aliment Pharmacol Ther, vol.45, issue.2, pp.222-261, 2017. ,
European consensus conference on faecal microbiota transplantation in clinical practice, Gut, vol.66, issue.4, pp.569-80, 2017. ,
Fecal microbiota transplantation: indications, methods, evidence, and future directions, Curr Gastroenterol Rep, vol.15, issue.8, p.337, 2013. ,
Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease, Aliment Pharmacol Ther, vol.36, issue.6, pp.503-519, 2012. ,
Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease, World J Gastroenterol, vol.19, issue.41, pp.7213-7219, 2013. ,
Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review, World J Gastroenterol, vol.21, issue.17, pp.5359-71, 2015. ,
Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature, Transpl Infect Dis Off J Transplant Soc, 2018. ,
Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis, Am J Gastroenterol, vol.108, issue.4, pp.500-508, 2013. ,
Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection, United Eur Gastroenterol J, vol.5, issue.6, pp.868-79, 2017. ,
Therapeutic potential of fecal microbiota transplantation, Gastroenterology, vol.145, issue.5, pp.946-53, 2013. ,
Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review, Ann Intern Med, vol.162, issue.9, pp.630-638, 2015. ,
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook, Gastroenterology, vol.149, issue.1, pp.223-260, 2015. ,
Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection, JAMA, vol.312, issue.17, pp.1772-1780, 2014. ,
Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology, Microb Biotechnol, vol.11, issue.1, pp.163-75, 2018. ,
Effect of Oral Capsule-vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial, JAMA, vol.318, issue.20, pp.1985-93, 201728. ,
Faecal microbiota transplantation with frozen capsules for relapsing Clostridium difficile infections: the first experience from 15 consecutive patients in France, J Hosp Infect, 2018. ,
Impact of, Gut Microbiota on Host Glycemic Control. Front Endocrinol, vol.10, p.29, 2019. ,
Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes, vol.8, pp.253-67, 201704. ,
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome, Gastroenterology, vol.143, issue.4, pp.913-916, 2012. ,
e6. ** This study confirmed the efficacy of FMT to improve insulin sensitivity in a larger group of patients and demonstrated the major variability of response, Cell Metab, vol.26, issue.4, pp.611-619, 2017. ,
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, Proc Natl Acad Sci, vol.110, issue.22, pp.9066-71, 2013. ,
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, Nat Med, vol.23, issue.1, pp.107-120, 2017. ,
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology, Gut, 2015. ,
Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans, Am J Clin Nutr, vol.94, issue.1, pp.58-65, 2011. ,
The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci, vol.101, issue.44, pp.15718-15741, 2004. ,
Gut microbiota from twins discordant for obesity modulate metabolism in mice, Science, vol.341, issue.6150, p.1241214, 2013. ,
The gut microbiome, diet, and links to cardiometabolic and chronic disorders, Nat Rev Nephrol, 2015. ,
Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice, Nutr Metab, vol.13, issue.1, p.57, 2016. ,
Weight Gain after Fecal Microbiota Transplantation in a Patient with Recurrent Underweight following Clinical Recovery from Anorexia Nervosa, Psychother Psychosom, vol.88, issue.1, pp.58-60, 2019. ,
Weight gain after fecal microbiota transplantation. Open Forum Infect Dis, vol.2, p.4, 2015. ,
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation, Am J Gastroenterol, vol.108, issue.10, pp.1620-1650, 2013. ,
Recovery of the gut microbiome following fecal microbiota transplantation. mBio, vol.5, pp.893-00814, 2014. ,
High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria, Gut Microbes, vol.4, issue.2, pp.125-160, 2013. ,
Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science, vol.352, pp.586-595, 2016. ,
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial, Gastroenterology, vol.149, issue.1, pp.102-109, 2015. ,
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Metaanalysis, J Crohns Colitis, vol.11, issue.10, pp.1180-99, 2017. ,
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease, J Crohns Colitis, vol.10, issue.4, pp.387-94, 2016. ,
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in dietinduced obese mice, Gut, vol.63, issue.5, pp.727-762, 2014. ,
Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice. Gut Microbes, pp.1-11, 2017. ,
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, vol.528, issue.7581, pp.262-268, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01535324
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug, Nat Med, vol.23, issue.7, pp.850-858, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01608413
Diet rapidly and reproducibly alters the human gut microbiome, Nature, vol.505, issue.7484, pp.559-63, 2014. ,
Linking long-term dietary patterns with gut microbial enterotypes, Science, vol.334, issue.6052, pp.105-113, 2011. ,
Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects, PloS One, vol.9, issue.10, p.109434, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01365890
Microbial ecology: human gut microbes associated with obesity, Nature, vol.444, issue.7122, pp.1022-1025, 2006. ,
An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases, EMBO Mol Med, vol.9, issue.1, pp.1-3, 2017. ,
, Effect of Vegan Fecal Microbiota Transplantation on Carnitine-and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in P, PubMed -NCBI, 2019.
Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review, vol.9, p.1599, 2017. ,
Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease, Oncotarget, vol.8, issue.51, pp.88894-903, 2017. ,
Patient perception and approval of faecal microbiota transplantation (FMT) as an alternative treatment option for obesity, Obes Sci Pract, vol.5, issue.1, pp.68-74, 2019. ,